SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 125 filers reported holding SUTRO BIOPHARMA INC in Q2 2021. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,850,027 | +90.4% | 533,149 | +155.1% | 0.01% | +66.7% |
| Q2 2023 | $971,869 | -84.8% | 209,004 | -73.6% | 0.00% | -86.4% |
| Q4 2022 | $6,388,048 | +61.9% | 790,600 | +11.2% | 0.02% | +37.5% |
| Q3 2022 | $3,946,000 | -44.3% | 711,000 | +89.6% | 0.02% | -48.4% |
| Q3 2021 | $7,084,000 | -66.5% | 375,000 | -67.0% | 0.03% | -67.4% |
| Q2 2021 | $21,129,000 | -3.1% | 1,136,600 | +18.6% | 0.10% | -6.9% |
| Q1 2021 | $21,809,000 | -28.7% | 958,200 | -32.0% | 0.10% | -31.5% |
| Q4 2020 | $30,596,000 | +201.3% | 1,409,314 | +39.5% | 0.15% | +186.5% |
| Q3 2020 | $10,155,000 | +118.1% | 1,010,495 | +68.4% | 0.05% | +73.3% |
| Q2 2020 | $4,656,000 | +26.9% | 600,000 | +86.1% | 0.03% | +57.9% |
| Q2 2019 | $3,669,000 | – | 322,377 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
| Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
| Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
| Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
| BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
| DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
| SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
| Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
| Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |